Guardant Health
418 hedge funds and large institutions have $13.9B invested in Guardant Health in 2021 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 143 increasing their positions, 153 reducing their positions, and 57 closing their positions.
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
30% more call options, than puts
Call options by funds: $118M | Put options by funds: $91.3M
24% more capital invested
Capital invested by funds: $11.3B → $13.9B (+$2.68B)
3.55% more ownership
Funds ownership: 87.43% → 90.99% (+3.6%)
9% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 57
0% more funds holding
Funds holding: 418 → 418 (0)
7% less repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 153
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$594M |
| 2 |
Coatue Management
New York
|
+$136M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$105M |
| 4 |
FAM
Fred Alger Management
New York
|
+$85.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$80.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$136M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$105M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$99.4M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$93.2M |
| 5 |
Morgan Stanley
New York
|
-$77.7M |
GH Hedge Fund Activity: Q1 2021 in Review
418 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q1 2021, worth a combined $13.9B — up 24% from $11.3B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new GH positions and 57 closed out — a net gain of 5 holders — while 143 added to existing stakes and 153 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $594M. The largest seller was Marshall Wace, cutting an estimated $136M.
- 418 institutional investors held Guardant Health (GH) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $13.9B of Guardant Health stock for Q1 2021, up 24% quarter-over-quarter.
- 62 funds opened new Guardant Health positions in Q1 2021 and 57 closed out, a net change of +5 holders.
- The largest Guardant Health buyer in Q1 2021 was Fidelity Investments, an estimated $594M added.
- The largest Guardant Health seller in Q1 2021 was Marshall Wace, an estimated $136M sold.
Based on aggregated 13F filings for Q1 2021.